Medtronic Neurovascular Clinical Affairs
Clinical trials sponsored by Medtronic Neurovascular Clinical Affairs, explained in plain language.
Clinical affairs division of Medtronic focused on neurovascular devices.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Brain aneurysm device under Real-World watch: will it hold up? Results expected Jan 2027 (estimated)
- New device aims to seal brain aneurysms without open surgery Results expected Aug 2027 (estimated)
-
Brain aneurysm device study halted early
Disease control Stopped earlyThis study looked at a device called the Pipeline Flex Embolization Device with Shield Technology to treat ruptured brain aneurysms that are hard to fix with surgery or coils. The goal was to see if it could safely block the aneurysm and prevent rebleeding. The study was stopped …
Sponsor: Medtronic Neurovascular Clinical Affairs • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Real-World data on brain aneurysm device could improve patient safety
Knowledge-focused Stopped earlyThis study observes people who have already been treated with the Pipeline Embolization Device for brain aneurysms. Researchers track neurological complications like stroke or bleeding to better understand the device's safety in everyday use. The goal is to expand knowledge on ho…
Sponsor: Medtronic Neurovascular Clinical Affairs • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC